Linda Oskam is currently in Myanmar and Nepal on a scoping mission for the Fleming Fund to assess the antimicrobial resistance (AMR) situation and the surveillance capacity in these countries.

The Fleming Fund is an initiative of the UK Department of Health and aims to support around 30 countries worldwide to improve their AMR surveillance capacity up to the level that they can report to GLASS (Global Antimicrobial Resistance Surveillance System). One Health, sustainability, country ownership and alignment with policies and other initiatives are crucial to the program.

Mott MacDonald serves as the Fleming Fund Management Agent and Linda was hired to serve as a laboratory expert during the inception phase. Currently, Mott MacDonald teams are carrying out scoping missions to get a better understanding of the AMR surveillance situation in Myanmar, Nepal, Ghana and Uganda, to raise awareness among stakeholders, to test the approaches and tools that were developed so far and (ultimately) to get grant proposals from the countries involved.

In Myanmar we had a meeting with the Minister of Health and Sports, His Excellency Dr. Myint Htwe, who was very supportive.